Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.

Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.
复制标题

DOI:
10.1021/nl2035354
复制
发表时间:
2012-01-11
期刊:
影响因子:
10.8
通讯作者:
DeSimone JM
DeSimone JM
中科院分区:
材料科学1区
文献类型:
--
作者:
Hasan W;Chu K;Gullapalli A;Dunn SS;Enlow EM;Luft JC;Tian S;Napier ME;Pohlhaus PD;Rolland JP;DeSimone JM

文献摘要

参考文献

被引文献

相似文献

纳米技术可以通过帮助提高新型治疗递送载体的安全性和有效性,在开发癌症管理和治疗策略方面提供关键优势。本文报道了通过称为PRINT(非润湿模板中的颗粒复制)的独特软光刻颗粒成型工艺制备的用于前列腺癌治疗的脂质包被的聚(乳酸-共-乙醇酸)/siRNA纳米颗粒的制造。PRINT工艺能够将siRNA高封装效率地封装到中性和单分散性PLGA颗粒中(32-46%封装效率)。脂质包被的PLGA/siRNA PRINT颗粒用于在体外递送治疗性siRNA以敲低与前列腺癌相关的基因。
Nanotechnology can provide a critical advantage in developing strategies for cancer management and treatment by helping to improve the safety and efficacy of novel therapeutic delivery vehicles. This paper reports the fabrication of poly(lactic acid-co-glycolic acid)/siRNA nanoparticles coated with lipids for use as prostate cancer therapeutics made via a unique soft lithography particle molding process called PRINT (Particle Replication In Nonwetting Templates). The PRINT process enables high encapsulation efficiency of siRNA into neutral and monodisperse PLGA particles (32–46% encapsulation efficiency). Lipid-coated PLGA/siRNA PRINT particles were used to deliver therapeutic siRNA in vitro to knockdown genes relevant to prostate cancer.
由于异常高的化学治疗载荷,有效的工程PLGA纳米颗粒。
DOI: 10.1021/nl104117p
发表时间: 2011-02-09
期刊: Nano letters
影响因子: 10.8
作者:
Enlow EM;Luft JC;Napier ME;DeSimone JM
通讯作者: DeSimone JM
DOI: 10.1021/mp200084y
发表时间: 2011-08-01
影响因子: 4.9
作者:
Patel PC;Hao L;Yeung WS;Mirkin CA
通讯作者: Mirkin CA
DOI: 10.1038/nature03121
发表时间: 2004-11-11
期刊: NATURE
影响因子: 64.8
作者:
Soutschek, J;Akinc, A;Vornlocher, HP
通讯作者: Vornlocher, HP
DOI: 10.1081/cnv-120016412
发表时间: 2003-01-01
影响因子: 2.4
作者:
Skubitz, KM
通讯作者: Skubitz, KM
DOI: 10.1073/pnas.1106379108
发表时间: 2011-08-09
影响因子: 11.1
作者:
Siegwart, Daniel J.;Whitehead, Kathryn A.;Anderson, Daniel G.
通讯作者: Anderson, Daniel G.